AFT Pharmaceuticals - Maxigesic international momentum continues
AFT Pharmaceuticals (AFT) has announced that it has signed three additional licensing agreements for Maxigesic IV – with Labatec in Switzerland and...
204 Views
AFT Pharmaceuticals: Breaking the Pain Barrier
AFT Pharmaceuticals' (AFT) notification of US FDA approval for its rapid release tablet form of Maxigesic provides a material long-term opportunity.
273 Views
AFT Pharmaceuticals (AFT): Maxigesic Rapid US Tablet Approval
AFT Pharmaceuticals (AFT) has today announced US FDA approval of its rapid release tablet form of Maxigesic, which is step one in the process for...
272 Views
AFT Pharmaceuticals - Big win with Maxigesic Rapid’s FDA nod
AFT Pharmaceuticals (AFT) has announced it has received FDA approval for Maxigesic Rapid tablets, a quick-release version of its flagship Maxigesic...
154 Views
AFT Pharmaceuticals - Portfolio expansion with new in-licensing deal
AFT Pharmaceuticals continues to strengthen its R&D pipeline with the announced in-licensing agreement with Latitude Pharmaceuticals (a...
235 Views